Meeting
2015 Gastrointestinal Cancers Symposium
A phase II clinical trial of carbon-ion radiotherapy and concurrent S-1 chemotherapy for locally advanced pancreatic cancer.
Authors
Makoto Shinoto
Ion Beam Therapy Center, SAGA HIMAT Foundation, Tosu, Japan
Makoto Shinoto , Yoshiyuki Shioyama , Hiroaki Suefuji , Akira Matsunobu , Shingo Toyama , Sho Kudo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
UMIN000013803
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr TPS504)
DOI
10.1200/jco.2015.33.3_suppl.tps504
Abstract #
TPS504
Poster Bd #
F19
Abstract Disclosures
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
A phase II study of biweekly gemcitabine at fixed dose rate infusion plus S1 as first-line chemotherapy in patients with locally advanced or metastatic pancreatic cancer.
First Author: Xj Xiang
Poster
2014 ASCO Annual Meeting
A phase II randomized, placebo controlled study to evaluate the efficacy of the combination of gemcitabine, erlotinib, and metformin in patients with locally advanced or metastatic pancreatic cancer.
First Author: Johanna Wilmink
Poster
2014 Gastrointestinal Cancers Symposium
Interim analysis of a phase II study of dose-modified FOLFIRINOX (mFOLFIRINOX) in locally advanced (LAPC) and metastatic pancreatic cancer (MPC).
First Author: Edward Samuel James
Poster
2024 ASCO Gastrointestinal Cancers Symposium
DIsCOvER: A multicenter, randomized, double-blind, placebo-controlled, phase III clinical trial to investigate the efficacy and safety of dronabinol in the improvement of chemotherapy-induced and tumor-related symptoms in patients with locally advanced or metastatic pancreas cancer during first-line chemotherapy.
First Author: Felix Keil